The Pfizer CEO Prediction That Could Mean Total COVID Market Dominance in 2022

Pfizer (NYSE:PFE) already is the leader in the coronavirus vaccine market. The big pharmaceutical company and partner BioNTech became the first to launch a vaccine. And that product now has fully vaccinated 49 million Americans. That's more than rivals Moderna and Johnson & Johnson. Pfizer recently forecast $15 billion in coronavirus vaccine revenue this year.

But Pfizer isn't stopping there. The company is now ready to conquer another massive coronavirus market. That move could give it ownership of the entire coronavirus space...and this dominance could be right around the corner.